Clinical Study

Gog-0212: A Randomized Phase III Trial Of Maintenance Chemotherapy Comparing 12, Monthly Cycles Of Single Agent Paclitaxel Or (Ct-2103) (Ind #70177),

Posted Date: May 15, 2019

  • Investigator: Eric Eisenhauer
  • Type of Study: Drug

In a prior study, a group of women with advanced ovarian cancer were treated with 5 or 6 cycles of chemotherapy until there was no sign of active cancer. The women were then divided into two groups. One group had no further treatment, while the second group continued to receive additional chemothera

Criteria:

You Have Ovarian, Primary Peritoneal Or Fallopian Tube Cancer That Has Been Confirmed By Surgery. Y

Keywords:

Ct-2103, Fallopiane Tube Or P, Gog 0212, Gynecologic Oncology, Ovarian Cancer

For More Information:

Michael Blakeman
513-584-5044
michael.blakeman@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.